Concepedia

Suman Chatterjee

SC

Statistics

Publications

5

Citations

384

H-Index

5

Active since

2017

Affiliations

UPMC Hillman Cancer Center(Current)

University of Pittsburgh

Johns Hopkins University

Johns Hopkins Medicine

Memorial Sloan Kettering Cancer Center

Suman Chatterjee is an author at UPMC Hillman Cancer Center specializing in oncology, molecular oncology, and oncogenic signaling pathways.

ORCID

Publications per year

2017–2018

5

Publications

5

Targeting the EMT transcription factor TWIST1 overcomes resistance to EGFR inhibitors in EGFR-mutant non-small-cell lung cancer

Zachary A. Yochum, Jessica Cades, Hailun Wang et al. · Oncogene · 2018 · 186 citations · Full text

, , +15

A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer

Zachary A. Yochum, Jessica Cades, Lucia Mazzacurati et al. · Molecular Cancer Research · 2017 · 92 citations

, , +14

Acquired Resistance to the Hsp90 Inhibitor, Ganetespib, in <i>KRAS-</i> Mutant NSCLC Is Mediated via Reactivation of the ERK–p90RSK–mTOR Signaling Network

Suman Chatterjee, Eric H.‐B. Huang, Ian Christie et al. · Molecular Cancer Therapeutics · 2017 · 48 citations · Full text

, , +17

HSP90 inhibition targets autophagy and induces a CASP9-dependent resistance mechanism in NSCLC

Jie Han, Leslie A. Goldstein, Wen‐Chi Hou et al. · Autophagy · 2018 · 40 citations · Full text

, , +17

Reactivation of the p90RSK–CDC25C Pathway Leads to Bypass of the Ganetespib-Induced G2–M Arrest and Mediates Acquired Resistance to Ganetespib in <i>KRAS</i> -Mutant NSCLC

Suman Chatterjee, Eric H.‐B. Huang, Ian Christie et al. · Molecular Cancer Therapeutics · 2017 · 18 citations · Full text

, , +17

1–5 of 5